ATE280574T1 - Isosorbiddinitrat enthaltendes pflaster - Google Patents

Isosorbiddinitrat enthaltendes pflaster

Info

Publication number
ATE280574T1
ATE280574T1 AT98900046T AT98900046T ATE280574T1 AT E280574 T1 ATE280574 T1 AT E280574T1 AT 98900046 T AT98900046 T AT 98900046T AT 98900046 T AT98900046 T AT 98900046T AT E280574 T1 ATE280574 T1 AT E280574T1
Authority
AT
Austria
Prior art keywords
isosorbide dinitrate
adhesive composition
adhesive
weight
component
Prior art date
Application number
AT98900046T
Other languages
English (en)
Inventor
Osafumi Hidaka
Satoshi Murakami
Yoshifusa Tachimori
Michisuke Ohe
Original Assignee
Teijin Ltd
Teysan Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd, Teysan Pharmaceuticals Co Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of ATE280574T1 publication Critical patent/ATE280574T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98900046T 1997-01-07 1998-01-06 Isosorbiddinitrat enthaltendes pflaster ATE280574T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP65197 1997-01-07
JP26164597 1997-09-26
PCT/JP1998/000009 WO1998030210A1 (en) 1997-01-07 1998-01-06 Patch containing isosorbide dinitrate

Publications (1)

Publication Number Publication Date
ATE280574T1 true ATE280574T1 (de) 2004-11-15

Family

ID=26333670

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98900046T ATE280574T1 (de) 1997-01-07 1998-01-06 Isosorbiddinitrat enthaltendes pflaster

Country Status (13)

Country Link
US (1) US6319515B1 (de)
EP (1) EP0900565B1 (de)
JP (1) JP3865787B2 (de)
KR (1) KR100337962B1 (de)
CN (1) CN1102384C (de)
AT (1) ATE280574T1 (de)
AU (1) AU735387B2 (de)
CA (1) CA2248167C (de)
DE (1) DE69827210T2 (de)
ES (1) ES2230666T3 (de)
NZ (1) NZ332192A (de)
TW (1) TW577750B (de)
WO (1) WO1998030210A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1212053A4 (de) * 1999-09-08 2004-08-11 Nitromed Inc Methoden zur behandlung und prophylaxe von kongestivem herzversagen durch hydralazinverbindungen und isosorbiddinitrat oder isosorbidmononitrat
US7537785B2 (en) * 1999-10-29 2009-05-26 Nitromed, Inc. Composition for treating vascular diseases characterized by nitric oxide insufficiency
US7708989B2 (en) * 1999-10-29 2010-05-04 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US7235237B2 (en) * 1999-10-29 2007-06-26 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
AU780261B2 (en) * 1999-10-29 2005-03-10 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
HK1040491A1 (en) * 2000-03-07 2002-06-14 Teijin Limited Stretchable patch
JP5021124B2 (ja) * 2001-08-29 2012-09-05 日東電工株式会社 医療用粘着組成物、それを用いた医療用粘着テープおよび経皮吸収用テープ製剤
DE10341933A1 (de) * 2003-09-11 2005-04-14 Lts Lohmann Therapie-Systeme Ag Medizinische Hautpflaster mit einem Gehalt an ätherischen Ölen zur Behandlung von Erkältungskrankheiten, sowie Verfahren für deren Herstellung
USD537947S1 (en) * 2004-06-10 2007-03-06 Hisamitsu Pharmaceutical Co., Inc. Medical patch
EP1778267A4 (de) * 2004-07-16 2010-01-06 Nitromed Inc Zusammensetzungen und verfahren in verbindung mit herzfehlfunktion
USD545441S1 (en) * 2004-12-01 2007-06-26 Hisamitsu Pharmaceutical Co., Inc. Medical patch
JP2006288887A (ja) * 2005-04-13 2006-10-26 Nitto Denko Corp 貼付製剤
WO2007065303A1 (en) * 2005-12-09 2007-06-14 Beijing Kangbeide Pharmaceutical Technology Development Co., Ltd. Transdermal patch containing isosorbide dinitrate and bisoprolol
WO2007097951A2 (en) * 2006-02-17 2007-08-30 Nitromed, Inc. Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
WO2007136626A1 (en) * 2006-05-16 2007-11-29 Nitromed, Inc. Solid dosage formulations of hydralazine compounds
JP5110712B2 (ja) * 2006-12-01 2012-12-26 日東電工株式会社 ドネペジル含有貼付製剤の経時的な変色を抑制する方法
RU2445953C2 (ru) * 2006-12-01 2012-03-27 Нитто Денко Корпорейшн Стабилизированная адгезивная композиция, содержащая донепезил
JP5235384B2 (ja) * 2007-11-08 2013-07-10 リンテック株式会社 貼付シート
CN102046171B (zh) * 2008-05-30 2013-06-19 日东电工株式会社 经皮吸收制剂
RU2481826C2 (ru) † 2008-05-30 2013-05-20 Нитто Денко Корпорейшн Содержащий донепезил адгезивный препарат и упаковка для него
JP2010163367A (ja) * 2009-01-13 2010-07-29 Nitto Denko Corp 貼付剤および貼付製剤
EA201500501A1 (ru) * 2010-07-29 2015-12-30 Сантен Фармасьютикал Ко., Лтд. Несущий корпус для лекарственного средства и способ его изготовления

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57116011A (en) 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
EP0223524B1 (de) 1985-11-08 1991-10-23 Nitto Denko Corporation Verwendung von Heftpflastern für die Haut und perkutanen Präparaten
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
DE69010317T3 (de) 1989-12-28 2000-10-12 Nitto Denko Corp., Ibaraki Acrylgel und seine Herstellung.
JP3223212B2 (ja) 1993-04-28 2001-10-29 ライオン株式会社 洗浄剤組成物
JP2945244B2 (ja) * 1993-05-24 1999-09-06 帝三製薬株式会社 酢酸ビニール系粘着剤を用いた硝酸イソソルビド含有貼付剤
JP3081413B2 (ja) 1993-06-03 2000-08-28 帝三製薬株式会社 混合系粘着剤を用いた硝酸イソソルビド含有貼付剤の製造方法
ES2122140T3 (es) * 1993-12-30 1998-12-16 Rotta Res Bv Parche transdermico con dinitrato de isosorbida como ingrediente activo.
AU689225B2 (en) * 1994-02-28 1998-03-26 Teijin Limited Patch containing isosorbide dinitrate and prepared by using adhesive mixture

Also Published As

Publication number Publication date
NZ332192A (en) 1999-02-25
TW577750B (en) 2004-03-01
KR20000064560A (ko) 2000-11-06
EP0900565A4 (de) 2001-01-03
JP3865787B2 (ja) 2007-01-10
CN1102384C (zh) 2003-03-05
US6319515B1 (en) 2001-11-20
DE69827210T2 (de) 2006-03-09
ES2230666T3 (es) 2005-05-01
WO1998030210A1 (en) 1998-07-16
CN1217656A (zh) 1999-05-26
EP0900565A1 (de) 1999-03-10
AU7994498A (en) 1998-08-03
CA2248167C (en) 2004-02-03
KR100337962B1 (ko) 2002-10-25
AU735387B2 (en) 2001-07-05
CA2248167A1 (en) 1998-07-16
EP0900565B1 (de) 2004-10-27
DE69827210D1 (de) 2004-12-02

Similar Documents

Publication Publication Date Title
DE69827210D1 (de) Isosorbiddinitrat enthaltendes pflaster
BR9911981A (pt) Esparadrapo tópico com anti-reumático não esteroidal com grupo ácido
DE69434507D1 (de) Haftklebstoffzusammensetzung und Klebeband, das diese verwendet
JPS57116011A (en) Pharmaceutical preparation
KR930703411A (ko) 상호침투하는 압감 접착제 중합체의 망상구조물
UA29400C2 (uk) Пластир для трансдермального введення нітрогліцерину та спосіб його виготовлення
CA2064325A1 (en) External preparation for application to the skin containing lidocaine
TR199501329A2 (tr) Protez dis sabitlestirme terkipleri.
CA2153572A1 (en) Transdermal therapeutic system with galanthamine as active ingredient
HUP9802361A2 (hu) Folyékony poliol-poliészter bőrpuhító bőrápoló szert és egy immobilizáló szert tartalmazó nedvesített fedőrésszel ellátott pelenka
FI921281A7 (fi) Liuottimettomia tai suuren kiintoainepitoisuuden omaavia, paineherkkiäsilikoniliimakoostumuksia
DE69229921D1 (de) Zusammensetzung, Klebstoff sowie wässrige Emulsion
ATE124872T1 (de) Oestrogenhaltiges gelpräparat.
DE69131073D1 (de) Makromonomere enthaltende druckempfindliche klebemittelzusammensetzungen aus polyolefin
NL174844C (nl) Drukgevoelige plakmiddelsamenstellingen, met een dergelijke samenstelling bekleed gevormd voortbrengsel, alsmede daaruit bestaande geharde, zelfdragende film.
DE60123529D1 (de) Buprenorphin hydrochlorid enthaltende pflaster
HUP9900315A2 (hu) Hőhatásra megolvadó, nyomásra tapadó ragasztókompozíciók és azok alkalmazása, valamint öntapadó szalagok, sebkötöző szerek, ragtapaszok és címkék
YU14394A (sh) Flaster sa aktivnom supstancom za davanje estradiola na kožu
CA2148112A1 (en) New pharmaeutical dosage form for transdermal administration
ATE86127T1 (de) Praeparat fuer die perkutane absorption und verfahren zu dessen herstellung.
FI963133A0 (fi) Dispersiolattialiima
EP0807674A3 (de) Druckempfindliche Klebmittelzusammensetzung enthaltend Styrol-Maleinsäure-Copolymerisate
MX9909797A (es) Composiciones para el cuidado personal que comprenden un copolimero adhesivo.
JPS5323336A (en) Thermoplastic rubber adhesion composition
ES2158937T3 (es) Parche que contiene dinitrato de isosorbida y que se prepara utilizando una mezcla de adhesivos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties